| Sep 30, 2011 | Sep 30, 2012 | Sep 30, 2013 | Sep 30, 2014 | Sep 30, 2015 | Sep 30, 2016 | Sep 30, 2017 | Sep 30, 2018 | Sep 30, 2019 | Sep 30, 2020 | Sep 30, 2021 | Sep 30, 2022 |
---|
Net income | -125,057 | -7,839,996 | -7,275,706 | -5,291,869 | 3 | 2 | 14 | -12 | -1 | 8 | 8 | 3 |
---|
Stock-based compensation expense | 1 | 3 | 3 | 3 | 3 | 4 | 5 | 9 | 10 | 10 | 12 | 13 |
---|
Amortization of intangible assets | - | - | - | - | 172,429 | 1 | 1 | 4 | 7 | 6 | 8 | 14 |
---|
Depreciation and amortization | 179,291 | 231,981 | 323,383 | 470,697 | - | - | 0 | 1 | 1 | 2 | 1 | 1 |
---|
Amortization of investment premiums & other | - | - | - | - | -425,941 | -0 | -0 | 0 | 0 | -0 | -1 | -2 |
---|
Investment Income, Amortization of Premium | - | - | - | - | - | - | - | - | - | - | 4 | 7 |
---|
Net changes in estimated fair value of acquisition-related contingent consideration | - | - | - | - | - | - | - | 2 | 0 | 0 | 1 | -1 |
---|
Deferred taxes | - | - | - | - | - | - | -11 | 4 | -4 | 2 | 0 | -4 |
---|
Accounts receivable | 2 | -1,862,555 | -391,543 | 1 | 566,069 | 1 | 2 | 6 | -2 | 0 | 1 | 11 |
---|
Contract assets | - | - | - | - | - | - | - | - | 2 | 7 | -1 | 2 |
---|
Other assets | - | 180,367 | -213,653 | 88,007 | 533,591 | 1 | -0 | 2 | 1 | -0 | 1 | -0 |
---|
Accounts payable | 130,393 | 353,043 | 1 | -83,642 | -448,833 | -0 | 1 | 0 | 0 | 0 | -2 | 2 |
---|
Accrued payroll and related taxes | 299,478 | 230,956 | 728,522 | -20,574 | 479,618 | 1 | 0 | 3 | -2 | 2 | 3 | -2 |
---|
Deferred revenue | - | - | - | - | - | - | - | - | 1 | 3 | 2 | 2 |
---|
Restructuring accrual | - | - | - | - | - | - | - | - | 2 | -2 | - | 1 |
---|
Other liabilities | - | - | - | - | 16,217 | -0 | 1 | 1 | 0 | -1 | 0 | 1 |
---|
Net cash provided by operating activities | 316,168 | -1,778,764 | -615,061 | - | - | - | 10 | 6 | 14 | 24 | 37 | 26 |
---|
Purchases of investments | 11 | 12 | 4 | 25 | 27 | 34 | 40 | 15 | 24 | 45 | 247 | 48 |
---|
Sales and maturities of investments | - | 15 | 6 | 12 | 21 | 31 | 33 | 41 | 15 | 21 | 90 | 173 |
---|
Acquisitions, net of cash acquired | - | - | - | - | 5 | - | - | 30 | - | - | 13 | 128 |
---|
Purchases of property and equipment | 204,358 | 339,715 | 1 | 135,452 | 73,126 | 0 | 0 | 4 | 1 | 1 | 1 | 1 |
---|
Net cash used in investing activities | -10,819,081 | 2 | 570,888 | - | - | - | -8 | -8 | -11 | -25 | -170 | -4 |
---|
Proceeds from Convertible Debt | - | - | - | - | - | - | - | - | - | - | 155 | - |
---|
Payment for convertible senior notes issuance costs | - | - | - | - | - | - | - | - | - | - | 6 | - |
---|
Purchase of 2026 convertible senior notes hedge | - | - | - | - | - | - | - | - | - | - | 33 | - |
---|
Proceeds from Issuance of Warrants | 37,917 | - | - | - | - | - | - | - | - | - | 24 | - |
---|
Proceeds from the issuance of equity plan common stock | - | - | - | - | - | - | - | - | - | - | - | 2 |
---|
Repurchases and retirements of common stock | - | - | - | - | - | - | - | - | - | 1 | 0 | 15 |
---|
Payment of acquisition-related contingent consideration | - | - | - | - | - | - | - | 1 | 1 | 0 | 1 | 8 |
---|
Principal payments on other borrowings | - | - | - | - | - | - | - | - | - | - | - | 0 |
---|
Net cash provided by (used in) financing activities | 15 | 717,371 | 17 | - | - | - | 1 | -0 | 4 | 3 | 144 | -21 |
---|
Foreign currency effect on cash and cash equivalents | - | - | - | - | - | - | - | - | -0 | 0 | -0 | 0 |
---|
Net increase in cash and cash equivalents | - | - | - | - | - | - | - | - | 8 | 3 | 10 | 2 |
---|
Cash paid for interest | - | - | - | - | - | - | - | 0 | - | - | 1 | 1 |
---|
Income Taxes Paid, Net | - | - | - | - | - | - | - | - | - | -0 | 1 | 1 |
---|
Reclassification Of Derivative Liability And Asset, Noncurrent To Additional Paid-In Capital | - | - | - | - | - | - | - | - | - | - | - | 29 |
---|
Acquisition-related shares issued | - | - | - | - | - | - | - | - | - | - | - | 2 |
---|
Unrealized holding gain (loss) on available-for-sale investments | -9,855 | 9,239 | 2,454 | -9,648 | 4,887 | 0 | -0 | -0 | 0 | 0 | -0 | 0 |
---|